臨床研究等提出・公開システム

Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for dilated cardiomyopathy (Follow-up trial) (Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for dilated cardiomyopathy (Follow-up trial))

Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for dilated cardiomyopathy (Follow-up trial)

Shigeru Miyagawa

The University of Osaka Hospital

2-15,Yamadaoka,Suita

saisentan@tissue.med.osaka-u.ac.jp

Takuji Kawamura

The University of Osaka Hospital

2-15,Yamadaoka,Suita

+81-6-6879-3154

saisentan@tissue.med.osaka-u.ac.jp

Not Recruiting

May. 12, 2025

Observational

single arm study

open(masking not used)

uncontrolled control

single assignment

treatment purpose

1) Patients who have undergone iPS cell derived-cardiomyocyte sheet (Clinical trial identification code:IPSOC-1) transplantation
2) Patients who can obtain concent to participate in this trial

None

Both

Dilated cardiomyopathy

D002311

Lifetime

1) Number and rate of clinical events of cardiac function such as death and hospitalization
2) Number and rate of tumor development events

+81-6-6210-8290

Mar. 11, 2025

Yes

The deidentified individual subject data will be used for conference presentations, research article,or both.If it is provided to the sponsor, it will be shared based on the contract.

none